+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Thrombosis: a major contributor to global disease burden.

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted-life-years (DALYs) lost in low- and middle-income countries, and second in high-income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilization of preventive measures will reduce the burden.

          Related collections

          Author and article information

          Semin. Thromb. Hemost.
          Seminars in thrombosis and hemostasis
          Oct 2014
          : 40
          : 7
          [1 ] College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
          [2 ] Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
          [3 ] Division of Hemostasia, Academia Nacional de Medicina, Buenos Aires, Argentina.
          [4 ] Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
          [5 ] Department of Hematology, SA Pathology, Flinders Medical Center, Adelaide, South Australia, Australia.
          [6 ] Thrombosis and Thrombophilia Centre, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom.
          [7 ] Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
          [8 ] Thrombosis Research Institute, London, United Kingdom.
          [9 ] Center for Thrombosis and Hemostasis, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
          [10 ] Department of Laboratory Medicine, University of Yamanashi, Yamanashi, Japan.
          [11 ] Thrombosis and Atherosclerosis Research Institute, and McMaster University, Hamilton, Ontario, Canada.
          Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.


          Comment on this article